Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India. Set up in 1978, Biocon is India’s first biotech company.

Following are the firsts from Biocon:

1. First Indian biotech company to receive US funding for proprietary technologies (1989)
2. Sets up India’s first clinical research organisation, Clinigene (2000)
3. First Indian company to be approved by US FDA for the manufacture of lovastatin, a cholesterol-lowering molecule (2001)
4. First company worldwide to develop human insulin on a Pichia expression system (2003)
5. Biocon enters the stock market with its IPO and becomes only the second Indian company to cross the $1-billion mark on the day of listing (2004)
6. Launches India’s first cancer drug, BIOMAb EGFR (2006)
7. First Indian company to manufacture and export enzymes to USA and Europe
8. India’s largest producer and exporter of enzymes
9. Releases country’s first 24-hour diabetes drug, Glargine (2009)
10. First biotech company to receive ISO 9001 certification in India